Mark R Hansen

Title: Mark R Hansen: Innovator in Pharmaceutical Chemistry

Introduction

Mark R Hansen is a notable inventor based in San Diego, CA, with a significant contribution to the field of pharmaceutical chemistry. He holds a total of five patents, showcasing his innovative approach to addressing medical challenges through chemical compounds.

Latest Patents

Among his latest patents, Hansen has developed benzimidazole derivatives as selective blockers of persistent sodium current. This invention is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof. The patent outlines pharmaceutical compositions comprising this compound and methods for treating diseases or conditions mediated by elevated persistent sodium current, such as ocular disorders, multiple sclerosis, seizure disorders, and chronic pain.

Career Highlights

Hansen has worked with prestigious organizations, including the Salk Institute for Biological Studies and Allergan, Inc. His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Throughout his career, Hansen has collaborated with esteemed colleagues, including Frederic D Bushman and George R Ehring. These collaborations have further enriched his research and innovation in the pharmaceutical field.

Conclusion

Mark R Hansen's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the medical field. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.